PCTY · Analyze — Financebot

position. First-ever /analyze on this name (no prior report existed) — the position had run unscored ([—] conviction) since it was added, and breached its legacy fixed-dollar trim ($150+) by 5.8% on 2026-08-27, triggering this pass per the Watchlist queue.

0. Knowledge check (done before researching)

python .mcp/kb.py find PCTY returned one live note: [[pitfall-quick-ratio-meaningless-for-payroll-processors]] — PCTY's quick ratio (0.094) and current ratio (1.089) are structurally depressed by client-fund liabilities and are not a liquidity signal. Applied below: liquidity is read from FCF margin and corporate cash instead. No SaaS-field sweep note mentions PCTY directly, but [[software-saas]] (the field-level sweep, as-of 2026-08-10) supplies the pricing-power/volume diagnostic used in the moat section, and the general vendor forward-P/E trap ([[pitfall-vendor-forward-eps-is-the-wrong-fiscal-year]]) was explicitly flagged as firing across the whole 8/27 batch — confirmed below, it fires on PCTY too.

1. General Health (Fundamentals)

TTM reconciliation. PCTY's fiscal year ends June 30, and FY2026 (ended 2026-06-30) is the most recently completed fiscal year — so the latest annual column is the TTM figure, no quarterly summation needed to reach it. Verified anyway, two ways:

Net income: Q1 FY26 ($47.991M) + Q2 ($50.197M) + Q3 ($111.250M) + Q4 ($60.303M) = $269.741M, ties to the annual $269.74M. Diluted EPS ≈ $4.93 ✓ (Q3, the calendar-Q1 tax season quarter, carries disproportionate income — the same seasonal signature Intuit shows; noted so a future analyst doesn't read one quarter as the year, per [[pitfall-single-quarter-fcf-read-as-ttm]]).
FCF: Q1 ($67.199M) + Q2 ($97.696M) + Q3 ($191.845M) + Q4 ($71.058M) = $427.798M, ties to fin.py's annual FCF of $427.80M and to OCF ($533.25M) − Capex ($105.45M).

🚩 New data-trap finding — the vendor snapshot FCF field is wrong here too. get_stock_info's freeCashflow field returns $359.87M, 16% below the reconciled $427.80M quarter-sum above. This is the same defect [[pitfall-yahoo-snapshot-fcf-field-diverges-from-quarter-sum]] recorded on DPZ (−19%) — PCTY is a fourth instance (after DPZ, GPN, LEU), same direction (vendor understates), different sector. Worth promoting that note's confidence from medium toward high. Do not quote freeCashflow from the snapshot for PCTY — use the quarterly-statement sum.

Metric	FY2023	FY2024	FY2025	FY2026 (=TTM)	CAGR
Revenue	$1.17B	$1.40B	$1.60B	$1.77B	14.7% (3yr)
Net income	$140.82M	$206.77M	$227.13M	$269.74M	24.2% (3yr)
FCF	$215.81M	$305.92M	$342.75M	$427.80M	25.6% (3yr)
Diluted shares	56.60M	56.98M	~55.4M	~55.0M (est.)	~flat/−0.5%

Only 3 years of clean annual data was available via fin.py/MCP (FY2022 income-statement fields were incomplete); this is short of the framework's preferred 5–8yr window. Flagged, not filled — a roic.ai deep-history pull would close the gap but was not judged worth the extra call for a HOLD-tier name already well below decision-threshold uncertainty.

Capital allocation, FY2026 ($427.8M FCF generated):

Use	FY2026	FY2025
Buybacks	$398.1M	$149.6M
Capex	$105.5M	$75.5M
Bolt-on M&A	$49.2M	$277.9M
Net debt repayment	~$85M (repaid $81.25M, issued $0)	net +$163M issued
Dividends	$0	$0

FY2026 buybacks alone ($398M) exceeded the entire year's FCF once M&A and capex are counted — funded partly from the $2.7B cash balance built by a debt raise in FY2025 (issued $325M, now largely repaid). Simply Wall St reports the buyback program was completed in the July print. Nearly all excess cash goes to repurchases; none to dividends. Shares outstanding fell from 55.37M (FY25) to 53.27M (FY26 year-end), a 3.8% reduction — the buyback is now visibly compounding, though the diluted weighted-average count (what EPS is computed on) has moved much less (~0.5% CAGR over 2yr) because new RSU issuance offsets the retirement pace. Watch this gap — per [[pattern-buyback-manufactured-eps-screens-as-growth]], a company can post EPS growth from share count alone while operating income is flatter than the EPS line implies. Here operating income did grow 27% in FY2026 (not flat), so this is a real-earnings-plus-buyback story, not a pure buyback illusion — but the SBC volume behind the RSU offset ($138.7M in FY2026, 7.8% of revenue) is a real economic cost the buyback is partially recycling, not adding on top of.

Debt-to-Assets: 2.72%. Total debt $133.0M against cash $271.9M — a net-cash balance sheet. D/E 10.9% (Yahoo's field, expressed as a percentage). No leverage risk.

Quick/current ratio (0.094 / 1.089): ignore, per the standing pitfall. These are structurally depressed by ~$3.5B of client-fund liabilities on the balance sheet, not a liquidity signal. Real liquidity read: 24% FCF margin, positive net cash, no near-term maturities. Fine.

Per-share: Revenue/share ≈ $32.2 (TTM revenue ÷ ~55M shares); FCF/share ≈ $7.78 (TTM FCF ÷ ~55M weighted-average diluted shares), up from ~$5.53 (FY24) — genuine per-share compounding even before crediting the buyback's acceleration into FY2027.

2. Moat & Competitive Advantage

Quantitative base. Gross margin 69.3% (fin.py), essentially flat to slightly improving over the period shown; operating margin 19.1% and rising (FY23: 13.3% → FY26: 19.1%). ROE 22.0% (inflated by the low, buyback-shrunk equity base — see the Graham caveat below), ROA 5.2% (a cleaner, unlevered read; solid but not exceptional for the multiple paid). No margin compression — the moat test in [[pattern-margin-intact-while-volume-falls-defers-the-damage]] would read this as an intact moat, but that framing needs pairing with the volume signal below, because margin can hold while the growth engine cools.

⚠️ Adjusted EBITDA is a much friendlier number than the underlying economics. The company's own FY2026 "Adjusted EBITDA" is $654.9M (37% margin) — but this excludes $138.7M of SBC (a real, recurring economic cost equal to 7.8% of revenue) and includes $120.0M of interest income on client float, a real but external, rate-sensitive revenue source that has nothing to do with the core payroll-processing business. Strip both and a more honest core-operating-EBITDA looks closer to the vendor GAAP-EBITDA figure (~$428–500M, 24–28% margin) — still healthy, but the headline "37% margin, growing" story oversells the core business's profitability. The company's own FY2027 guide separates this cleanly ($690–700M including interest income, $587–597M excluding it) — use the ex-interest number as the comparable one.

Interest income on client float — the guard's flagged mechanism, now working in reverse. This is real and rate-sensitive (same mechanism as ADP), and it is currently a headwind, not a tailwind: FY2026 delivered $120.0M; FY2027 guidance assumes ~$103M (−14% YoY) on two expected 25bp rate cuts in 2H FY27. A component of FY2026's reported growth was riding a higher-rate environment that is now normalizing away — this is not disclosed anywhere in a single ratio, only in guidance commentary, exactly the kind of thing [[software-saas]]'s pricing-power diagnostic warns a screen cannot see.

Adversarial stress-test. "You are a well-funded rival — how easily do you take this business?" Not easily, but not as hard as a legacy payroll incumbent either. PCTY's moat is the standard payroll processor's: switching costs. Migrating payroll/tax/compliance systems mid-year is expensive, disruptive, and carries real compliance risk — third-party estimates put full-suite migration cost at $30–80K plus ongoing integration overhead for a mid-market buyer. That is a genuine retention mechanism, the same one that lets ADP and PAYX compound for decades. But the mid-market HCM segment PCTY plays in is more contested than ADP's enterprise tier: Rippling (well-funded, unifies HR/IT/finance, aggressive expansion), Gusto (owns the smaller end), Dayforce/UKG (push down from the upper-mid), and Paycom/isolved (direct mid-market peers) are all live competitive threats, not theoretical ones.

Revenue-stream map. Recurring & other revenue $1.651B (+12.2% YoY, 93% of total) — the overwhelming majority is genuinely recurring, subscription-like payroll/HCM SaaS revenue billed per-employee-per-month. Interest income on client float ($120M, ~7% of total revenue) sits alongside it as a smaller, external, rate-dependent stream. Client base grew 7% to ~44,400 — itself a deceleration from PCTY's historical new-logo pace.

🔻 The market's actual concern, and it is legitimate. StockStory (and the market) flags: (1) net revenue retention of 92% in Q1 — meaning, absent new-logo wins, the existing book would shrink 8% a year; that is below the 100%+ bar that marks an expanding SaaS installed base, and is the clearest single number that the moat, while real, is not currently strengthening the book from within. (2) Revenue growth guided to ~7% for FY2027, a sharp deceleration from the 22.7% five-year historical CAGR and from FY2026's 11%. Some of that deceleration is mix/maturation (a $1.77B-revenue company cannot keep compounding at 20%+ forever), some is the float-income reversal above, and some is genuine competitive pressure in a segment that has gotten more crowded since PCTY's early-2020s hyper-growth phase.

Disruption forecast (5–10yr). The near-term disruption vector is competitive share loss to better-funded, more horizontally-integrated rivals (Rippling especially), not technological obsolescence — payroll/tax compliance is not an easy target for AI-native disruption given the regulatory surface area, and PCTY is itself deploying AI (the "Ignite AI" rollout referenced in FY2027 guidance, plus an AI-recruiting partnership announced 2026-08-27) as a retention/cross-sell lever rather than a defense against disruption. Longer-run, AI-driven headcount compression at PCTY's customers is a real but second-order risk — PCTY bills per-employee, so if AI genuinely shrinks client headcounts at scale, revenue is exposed the same way MNDY's per-seat model was (see [[software-saas]]'s pricing-meter taxonomy). Not yet visible in the numbers, worth tracking.

Evergreen assessment. Payroll processing is a durable, unglamorous, recurring-need business — genuinely evergreen at the category level (ADP has compounded for 70+ years on the same core mechanism). PCTY's own durability inside that category is good-not-great: real switching-cost moat, softening retention, and a growth rate now converging toward the sector's mature-processor peers (ADP, PAYX) rather than staying in hyper-growth territory. Moat rating: solid but not strengthening — 6.0/10.

3. Valuation

Step 0 — the vendor forward P/E trap fires here, exactly as flagged. forwardPE (16.33x) prices forwardEps ($9.686) — but cross-checking epsCurrentYear/priceEpsCurrentYear shows $8.720 / 18.14x. PCTY's FY2026 just closed (lastFiscalYearEnd 2026-06-30), so the "current year" by Yahoo's convention is the in-progress FY2027 (ends 2027-06-30); nextFiscalYearEnd confirms this. That makes forwardPE's $9.686 estimate an FY2028 figure — a year beyond the one that should be quoted as "forward." The vendor number overstates cheapness by roughly two multiple points on a company already near a full valuation — the same direction, same mechanism, as every other name in the 8/27 batch.

Basis	Vendor field	Value	True year	True read
Vendor "forward P/E"	`forwardPE`	16.33x	FY2028 (~2yr out)	Discard
True current-year (FY2027)	`priceEpsCurrentYear`	18.14x	FY2027, in progress	Use this
Trailing (TTM, GAAP)	`trailingPE`	32.08x	FY2026, closed	Clean, unambiguous denominator

Because the "current-year" EPS figure ($8.72) is almost certainly a non-GAAP consensus (SBC and amortization added back — standard for SaaS, and roughly consistent with Q4 FY26's reported non-GAAP EPS of $1.84), it is not directly comparable to the $4.93 GAAP TTM figure without adjustment — the 72% jump is not a fiscal-year-mapping error like TSM/QCOM, it is a GAAP-vs-non-GAAP basis difference layered on top of real (if decelerating) growth. Given that ambiguity, this report sets the watchlist trim on the unambiguous ttm GAAP multiple rather than the fwd figure, per [[pitfall-multiple-trim-inherits-the-broken-vendor-field]]'s standing guidance.

Graham's Intrinsic Value: √(22.5 × 4.93 × 22.061) ≈ $49.47 vs. spot $158.15. Not meaningful here and stated as such rather than waved away — Graham's formula penalizes low book value per share, and PCTY's BVPS ($22.06) is artificially compressed by years of aggressive buybacks retiring equity, not by weak fundamentals. Per the framework, Graham should carry little weight for a non-dividend, asset-light, high-ROE compounder; it is reported for completeness and discarded from the fair-value synthesis.

FCF-multiple approach (the one that matters here): TTM FCF/share ≈ $7.78. At a 18–24x FCF multiple — reasonable for a moated, still-double-digit-EPS-growth SaaS name with a cooling top line — fair value lands at $140–$187. At the current 20.5x TTM P/FCF the market is pricing it almost exactly at the midpoint of that band.

Bogle's Expected Return: dividend yield 0% + earnings growth (non-GAAP consensus implies roughly low-to-mid-teens EPS growth into FY2027, driven by the accounting-life extension +120–140bps margin tailwind and continued buybacks against a decelerating ~7% revenue base) ± multiple change. If the ~18x current-year multiple holds, expected return ≈ +12–15%/yr. If the multiple compresses toward the mature-processor peer band (ADP/PAYX typically trade mid-to-high-20s trailing, but those are higher-quality, higher-NRR compounders) to reflect the NRR softness, expected return could flatten to low-single-digits or worse. This is the real tension in the name: priced for continued mid-teens bottom-line growth, while the top-line and retention numbers are both decelerating.

DYT / DDM: not applicable — PCTY pays no dividend (payout ratio 0.00).

Fair value range: $135–175, built from the FCF-multiple approach (weighted heaviest, per framework guidance for non-dividend growth names) and cross-checked against the corrected current-year earnings multiple. Current price $158.15 sits inside this range, closer to its midpoint than either edge — fairly priced, not cheap, not absurd.

4. Type-Specific Overlay — none of the standard overlays (REIT/BDC/Dividend-Grower) apply; this is

a straight non-dividend SaaS name, covered by §1–§3 plus the field-level SaaS diagnostic below.

Applying the [[software-saas]] pricing/volume diagnostic: PCTY bills per-employee-per-month (seat-equivalent) — the same exposure class as MNDY/TEAM/ASAN in the field sweep, i.e. structurally exposed to AI-driven seat compression if that materializes at scale, and structurally dependent on new-logo volume and stable NRR to keep growing once a pricing lap (if any) completes. No evidence of a specific pricing-action lap here (unlike MNDY) — the deceleration reads as organic maturation plus competitive pressure plus the float-income reversal, not a one-time pricing cliff. That is a somewhat more benign diagnosis than MNDY's, but the NRR softness (92%) means the volume side of the equation is already showing strain, not just a risk to watch.

5. Sentiment & Intelligence

Q4/FY2026 print (2026-08-04): revenue beat ($444.7M vs. $431.4M consensus), FY2026 adj. EBITDA $654.9M, FCF +24.8% YoY. Stock reaction was initially soft on the FY2027 guide (deceleration to ~7–8% revenue growth), with the name drifting to the high-$140s by mid-August, before rallying strongly through late August (+4.0% on 2026-08-27 alone, now $158.15, a "Golden Cross" technical signal per Zacks 2026-08-20) as sell-side price targets were raised repeatedly: TD Cowen $177, KeyBanc $178, BTIG $180, Cantor Fitzgerald $165, Barclays $154 — average analyst rating 1.45 (Strong Buy), target mean $172, target range a wide $128–250.
2026-08-27 (today): Simply Wall St reports an AI-powered recruiting partnership with "a major client" — a cross-sell/AI-monetization data point, consistent with the "Ignite AI" rollout theme.
🔻 Insider activity — no purchases, a heavy and sustained selling cadence. Every logged Form-4 transaction in the past 12 months is a sale (or a zero-value RSU grant) — CEO Toby Williams, CFO Ryan Glenn, Chairman Steven Beauchamp, Founder/Director Steven Sarowitz (particularly active — dozens of sales through 2025–2026), and several other officers, essentially every trading window since November 2024. No golden flag here. This reads as routine post-vest liquidation (values are modest relative to each holder's stake, and the pattern is steady rather than concentrated around the guide-down) rather than a coordinated exit signal, but it is worth noting plainly: insiders have not been buying the dip at any point in the past year, including at the recent $147 low.
Bear case (StockStory, recurring across 2025–2026): decelerating ARR growth, sub-100% NRR (92%), revenue growth guide well below the 5yr historical CAGR — the same three points this report independently surfaced from the primary data.

6. Synthesis & Verdict

Two questions, per the framework's first principle:

Is this a good business? Yes, with a real caveat. PCTY has a genuine switching-cost moat, a clean balance sheet, expanding operating margins, and a buyback program now visibly compounding per-share value. But the moat is not currently widening — NRR at 92% and a guided deceleration to ~7% revenue growth (from a 22.7% five-year CAGR) mark a business converging toward mature-payroll-processor growth rates (ADP/PAYX territory) faster than the multiple has caught up to.
Has the market priced that in? Mostly. The corrected fair-value range ($135–175) contains the current $158.15 price near its midpoint. The stock's legacy $150+ trim, which the position nominally "breached" by 5.8%, was a stale fixed-dollar level from an earlier, cheaper entry point — not a re-derived ceiling. Properly re-underwritten, this is not an overvaluation signal; it is a stale-trim artifact, the same pattern the 8/27 batch found repeatedly on other names (see AMD).

Weighting: for a high-growth-turning-moderate-growth SaaS name, Moat + Sentiment carry more weight than Graham's static valuation (correctly discarded above), but the FCF-multiple valuation and the NRR/growth-deceleration read from Fundamentals/Sentiment are the deciding factors here, and they point the same direction: fairly priced, real business, real deceleration, no clear edge either way.

Verdict: HOLD. Conviction 5.5/10. Don't add at $158 — the entry zone worth adding at is $120–135 (24–27x TTM EPS, roughly the 50/200-day moving-average zone), where the growth-quality questions would be more than compensated for by price. Don't trim reflexively on the stale legacy level either — the re-derived ceiling is 35x TTM EPS (~$173), above the current price, so this is not yet a harvest-the-gain situation on valuation grounds alone. Revisit hard at the Q1 FY27 print (early November 2026) — the first quarter that will show whether NRR stabilizes or keeps eroding, and the first read on whether the guided interest-income decline is landing as modeled.

Key Risks

NRR erosion (92%) continuing — if it keeps falling, new-logo growth alone will not be enough to hold even the guided ~7% revenue growth, and the "still-growing compounder" part of the bull case breaks.
Competitive share loss to Rippling (well-funded, horizontally integrated) and Dayforce/UKG pushing down-market — the switching-cost moat protects the existing book, not new-logo share.
Interest-income reversal executing worse than guided — a steeper/faster Fed cutting cycle than the "two 25bp cuts in 2H FY27" assumption would pressure the ex-interest-income EBITDA story further, since $103M of FY2027's guided profitability is not core-business economics.
No insider buying at any point in the past year, including the recent low — not disqualifying on its own, but it removes a signal that would otherwise support conviction at these levels.

Data Traps Hit

[[pitfall-vendor-forward-eps-is-the-wrong-fiscal-year]] — confirmed on PCTY. forwardPE (16.33x) prices an FY2028 estimate; priceEpsCurrentYear (18.14x) is the true current-year (FY2027) read. Trim set on TTM instead, per that note's standing guidance for disagreeing vendor fields.
[[pitfall-quick-ratio-meaningless-for-payroll-processors]] — confirmed again (quick ratio 0.094, current ratio 1.089); ignored per the existing note, liquidity read from FCF margin/net cash instead.
New finding, not yet in the Playbook: get_stock_info's freeCashflow snapshot field ($359.87M) understates PCTY's reconciled TTM FCF ($427.80M, quarter-sum, two ways) by 16% — a fourth instance of [[pitfall-yahoo-snapshot-fcf-field-diverges-from-quarter-sum]] (after DPZ, GPN, LEU), same direction (vendor low), different sector (payroll/HCM vs. restaurant/payments/uranium). Worth an amendment upgrading that note's confidence from medium.